Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence

Sonal Ghura Mansukhani,1 Elizabeth A MacLean,2 Laura L Manzey,2 Carl J Possidente,2 Joseph C Cappelleri,2 Linda S Deal2 1Patient Centered Outcomes Research, Evidera, Waltham, Massachusetts, USA; 2Medical Outcomes Specialists (EAM, LLM, CJP); Patient Centered Outcome Assessment (LSD); Biostatistics (...

Full description

Bibliographic Details
Main Authors: Mansukhani SG, MacLean EA, Manzey LL, Possidente CJ, Cappelleri JC, Deal LS
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/development-of-a-new-patient-reported-medication-adherence-instrument--peer-reviewed-fulltext-article-PPA
id doaj-c4d735f77d8344d598704c225ff9a7f8
record_format Article
spelling doaj-c4d735f77d8344d598704c225ff9a7f82021-09-09T19:31:53ZengDove Medical PressPatient Preference and Adherence1177-889X2021-09-01Volume 151991200768665Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication AdherenceMansukhani SGMacLean EAManzey LLPossidente CJCappelleri JCDeal LSSonal Ghura Mansukhani,1 Elizabeth A MacLean,2 Laura L Manzey,2 Carl J Possidente,2 Joseph C Cappelleri,2 Linda S Deal2 1Patient Centered Outcomes Research, Evidera, Waltham, Massachusetts, USA; 2Medical Outcomes Specialists (EAM, LLM, CJP); Patient Centered Outcome Assessment (LSD); Biostatistics (JCC), Pfizer Inc., New York, NY, USACorrespondence: Linda S Deal Email Linda_Deal@yahoo.comPurpose: The purpose of this research was to conceptualize and develop a tool for identifying persons who are, or are likely to be, non-adherent to medications prescribed by their healthcare provider(s) by identifying concerns that patients have regarding their treatments.Patients and Methods: The target populations were persons diagnosed with atrial fibrillation or osteoarthritis, who were prescribed anticoagulants or over-the-counter or prescription pain medications, respectively. In this two-stage, multi-year, qualitative research study, relevant concepts were explored, confirmed and refined. The focus was on non-adherence due to active (thus potentially modifiable) patient decisions to forego taking medications as prescribed.Results: The most common concerns among participants with atrial fibrillation were medication-related side effects and fear of bleeding. Participants with osteoarthritis were most concerned about short-term stomach problems and long-term kidney and liver side effects. The Concerns Influencing Medication Adherence (CIMA) instrument was developed based on these concerns and those identified in the literature. It is comprised of 16 items: a core set of 11 items potentially applicable to multiple disease states, 3 items specific to atrial fibrillation, and 2 items unique to osteoarthritis. The instrument is intended to be completed electronically, and publicly available for use in direct patient care in the United States or in population health management.Conclusion: To our knowledge, this is the first instrument focused on medication adherence that includes documented details of patient input as recommended by the United States Food and Drug Administration guidance. Patient input is considered a key component of content validity. In this research, for example, the concerns that patients have regarding their treatments can be expected to have affected past medication adherence and can potentially impact future adherence. Although applicability outside atrial fibrillation or osteoarthritis was not assessed, the general items may be useful in assessing adherence in other chronic diseases.Keywords: medication adherence, content validity, patient-reported outcome, atrial fibrillation, osteoarthritishttps://www.dovepress.com/development-of-a-new-patient-reported-medication-adherence-instrument--peer-reviewed-fulltext-article-PPAmedication adherencecontent validitypatient reported outcomeatrial fibrillationosteoarthritis
collection DOAJ
language English
format Article
sources DOAJ
author Mansukhani SG
MacLean EA
Manzey LL
Possidente CJ
Cappelleri JC
Deal LS
spellingShingle Mansukhani SG
MacLean EA
Manzey LL
Possidente CJ
Cappelleri JC
Deal LS
Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence
Patient Preference and Adherence
medication adherence
content validity
patient reported outcome
atrial fibrillation
osteoarthritis
author_facet Mansukhani SG
MacLean EA
Manzey LL
Possidente CJ
Cappelleri JC
Deal LS
author_sort Mansukhani SG
title Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence
title_short Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence
title_full Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence
title_fullStr Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence
title_full_unstemmed Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence
title_sort development of a new patient-reported medication adherence instrument: concerns influencing medication adherence
publisher Dove Medical Press
series Patient Preference and Adherence
issn 1177-889X
publishDate 2021-09-01
description Sonal Ghura Mansukhani,1 Elizabeth A MacLean,2 Laura L Manzey,2 Carl J Possidente,2 Joseph C Cappelleri,2 Linda S Deal2 1Patient Centered Outcomes Research, Evidera, Waltham, Massachusetts, USA; 2Medical Outcomes Specialists (EAM, LLM, CJP); Patient Centered Outcome Assessment (LSD); Biostatistics (JCC), Pfizer Inc., New York, NY, USACorrespondence: Linda S Deal Email Linda_Deal@yahoo.comPurpose: The purpose of this research was to conceptualize and develop a tool for identifying persons who are, or are likely to be, non-adherent to medications prescribed by their healthcare provider(s) by identifying concerns that patients have regarding their treatments.Patients and Methods: The target populations were persons diagnosed with atrial fibrillation or osteoarthritis, who were prescribed anticoagulants or over-the-counter or prescription pain medications, respectively. In this two-stage, multi-year, qualitative research study, relevant concepts were explored, confirmed and refined. The focus was on non-adherence due to active (thus potentially modifiable) patient decisions to forego taking medications as prescribed.Results: The most common concerns among participants with atrial fibrillation were medication-related side effects and fear of bleeding. Participants with osteoarthritis were most concerned about short-term stomach problems and long-term kidney and liver side effects. The Concerns Influencing Medication Adherence (CIMA) instrument was developed based on these concerns and those identified in the literature. It is comprised of 16 items: a core set of 11 items potentially applicable to multiple disease states, 3 items specific to atrial fibrillation, and 2 items unique to osteoarthritis. The instrument is intended to be completed electronically, and publicly available for use in direct patient care in the United States or in population health management.Conclusion: To our knowledge, this is the first instrument focused on medication adherence that includes documented details of patient input as recommended by the United States Food and Drug Administration guidance. Patient input is considered a key component of content validity. In this research, for example, the concerns that patients have regarding their treatments can be expected to have affected past medication adherence and can potentially impact future adherence. Although applicability outside atrial fibrillation or osteoarthritis was not assessed, the general items may be useful in assessing adherence in other chronic diseases.Keywords: medication adherence, content validity, patient-reported outcome, atrial fibrillation, osteoarthritis
topic medication adherence
content validity
patient reported outcome
atrial fibrillation
osteoarthritis
url https://www.dovepress.com/development-of-a-new-patient-reported-medication-adherence-instrument--peer-reviewed-fulltext-article-PPA
work_keys_str_mv AT mansukhanisg developmentofanewpatientreportedmedicationadherenceinstrumentconcernsinfluencingmedicationadherence
AT macleanea developmentofanewpatientreportedmedicationadherenceinstrumentconcernsinfluencingmedicationadherence
AT manzeyll developmentofanewpatientreportedmedicationadherenceinstrumentconcernsinfluencingmedicationadherence
AT possidentecj developmentofanewpatientreportedmedicationadherenceinstrumentconcernsinfluencingmedicationadherence
AT cappellerijc developmentofanewpatientreportedmedicationadherenceinstrumentconcernsinfluencingmedicationadherence
AT dealls developmentofanewpatientreportedmedicationadherenceinstrumentconcernsinfluencingmedicationadherence
_version_ 1717758880739491840